Last updated: 2026-09-23 10:09:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Rafael Holdings, Inc. (RFL) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $2,01, with a market capitalization of $104,00M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1,12 to $3,96. This page covers its latest market performance, valuation, price trends and company information.
$104,00M | |
$1,97 | |
$400,02 | |
$0,15 | |
$2,00 | |
99,95K | |
159,95K | |
-- | |
$3,96 | |
$1,12 | |
-- | |
-- |
Rafael Holdings, Inc. (RFL) is trading at $2,06 in pre-market trading as of 2026-09-22 23:31:00, up 2,75% ($0,06) from the previous close of $2,00
Pre-market trading shows how investors are pricing RFL before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Over the past seven days, Rafael Holdings, Inc. (RFL) moved from $2,18 to $2,01, representing a decline of 7,80% ($0,17).
The stock traded between $1,95 and $2,32 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 109,57 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 31,3%
RFL is currently trading at $2,01, placing it 31,3% of the way from its 52-week low of $1,12 to its 52-week high of $3,96. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 23 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Rafael Holdings, Inc. (RFL) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.